RxDoctor Payments Data

Regina Morris Solis, MD

Pain Medicine · Melbourne, FLNPI 1477823904

Payments from drug & device makers

$1,349in general payments, 2019–2025

Across 53 payments — averaging $25.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scilex Pharmaceuticals Inc.$326
  • Medtronic$206
  • Almatica Pharma LLC$151
  • Relievant Medsystems, Inc.$150
  • Abbott$97
  • Stimwave Technologies Incorporated$81
  • plus $339 from 11 others

What the payments were for

  • Food & beverage$1,349100%
  • Gifts$00%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,349 in reported general payments places this provider in the 40th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida

Medicare billing

Part B allowed, 2024
$255,933
Medicare patients
312
Services billed
13,615

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl14$8,140
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen230$7,700
ZtlidoLidocaine15$7,634
Lubiprostone47$4,374
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen174$3,362
Oxycodone Hcl226$2,866
Pregabalin127$1,992
Morphine Sulfate ErMorphine Sulfate44$1,127
Hydromorphone Hcl51$887
Celecoxib26$724
Gabapentin65$593
Tizanidine Hcl56$421
Methocarbamol41$412
Morphine Sulfate16$315
Tramadol Hcl50$290

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Scilex Pharmaceuticals Inc.Ztlido$326$7,63415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 596 pain medicine providers in Florida.

Other pain medicine in Melbourne

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →